In CDX2− CMS4 tumours TGFβ may polarize infiltrating lymphocytes towards a more regulatory phenotype, with less potent antitumour effector functions27, whereas in CDX2− CMS1 tumours the absence of TGFβ may result in a more robust cytotoxic T‐cell response18. Here, TGFB1 is linked to neoplasm.